Video Series: Our Team
Health Topics: Genetics
Dr. Summar discussing genetics department (1 of 3)
"All in all, Hanan has been a joy and I think coping with challenges may make her even stronger. I know I am wiser, having met extraordinary people on this journey. I think you will too."
Read More of Hanan's Story
Invest in future cures for some of life's most devastating diseases
Keep in touch with Children's National by signing up for our newsletters.
Pediatric Specialists of Virginia begins operations as a collaboration between Children's National and Inova.
Marshall Summar, MD, talks to other genetics specialists about the impact of genetics on the field of cardiology.
A novel anti-inflammatory in development for the chronic treatment of Duchenne muscular dystrophy by ReveraGen BioPharma, a private spin-off company from Children’s National Health System, has received $2 million from four nonprofit organizations.
Kenneth Rosenbaum, MD, speaks with Parents.com about Down syndrome.